Yoshihiko Hatanaka
Director/Board Member bei SONY GROUP CORPORATION
Profil
Derzeit ist Yoshihiko Hatanaka Chairman von Astellas Pharma, Inc. Er ist außerdem im Vorstand der Sony Corp. In seiner früheren Laufbahn war er Chairman & Chief Executive Officer bei Astellas Pharma US, Inc. sowie President & Chief Executive Officer bei Astellas US LLC und Director-Corporate Planning bei Fujisawa Pharmaceutical Co., Ltd. Er erhielt einen Bachelor-Abschluss von der Universität Hitotsubashi.
Aktive Positionen von Yoshihiko Hatanaka
| Unternehmen | Position | Beginn |
|---|---|---|
| SONY GROUP CORPORATION | Director/Board Member | 18.06.2019 |
| SHISEIDO COMPANY, LIMITED | Director/Board Member | - |
Ehemalige bekannte Positionen von Yoshihiko Hatanaka
| Unternehmen | Position | Ende |
|---|---|---|
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Chairman | 01.03.2009 |
Astellas US LLC
 Astellas US LLC Pharmaceuticals: MajorHealth Technology Part of Astellas Pharma, Inc., Astellas US LLC is a private company that manufactures and markets pharmaceutical products. The company is based in Northbrook, IL. The CEO of the company is Kenji Yasukawa. | Chief Executive Officer | - |
Fujisawa Pharmaceutical Co., Ltd.
 Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP | Corporate Officer/Principal | - |
| ASTELLAS PHARMA INC. | Chief Executive Officer | 01.04.2018 |
Ausbildung von Yoshihiko Hatanaka
| University of Hitotsubashi | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SONY GROUP CORPORATION | Electronic Technology |
| SHISEIDO COMPANY, LIMITED | Consumer Non-Durables |
| ASTELLAS PHARMA INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Fujisawa Pharmaceutical Co., Ltd.
Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP | Health Technology |
Astellas Pharma US, Inc.
Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Health Technology |
Astellas US LLC
Astellas US LLC Pharmaceuticals: MajorHealth Technology Part of Astellas Pharma, Inc., Astellas US LLC is a private company that manufactures and markets pharmaceutical products. The company is based in Northbrook, IL. The CEO of the company is Kenji Yasukawa. | Health Technology |
